Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBEAL1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYP20A1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
CARF - Glucosamine treatment effect on KMH2 malignant lymphocytes
WDR12 - Glucosamine treatment effect on KMH2 malignant lymphocytes
ABI2 - Glucosamine treatment effect on KMH2 malignant lymphocytes
ICA1L - Glucosamine treatment effect on KMH2 malignant lymphocytes
RAPH1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
FAM117B - Glucosamine treatment effect on KMH2 malignant lymphocytes
CD28 - Glucosamine treatment effect on KMH2 malignant lymphocytes
BMPR2 - Glucosamine treatment effect on KMH2 malignant lymphocytes
CTLA4 - Glucosamine treatment effect on KMH2 malignant lymphocytes
ICOS - Glucosamine treatment effect on KMH2 malignant lymphocytes
NOP58 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SUMO1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
KIAA2012 - Glucosamine treatment effect on KMH2 malignant lymphocytes
PARD3B - Glucosamine treatment effect on KMH2 malignant lymphocytes
NRP2 - Glucosamine treatment effect on KMH2 malignant lymphocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on